메뉴 건너뛰기




Volumn 9, Issue 1, 2015, Pages 31-35

Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods

Author keywords

Cytokines; Leucocytes; Platelet concentrate

Indexed keywords


EID: 84923372343     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.150945     Document Type: Article
Times cited : (9)

References (14)
  • 1
    • 0028117243 scopus 로고
    • Cytokine generation in stored platelet concentrates
    • Stack G, Synder EL. Cytokine generation in stored platelet concentrates. Transfusion 1994;34:20-5.
    • (1994) Transfusion , vol.34 , pp. 20-25
    • Stack, G.1    Synder, E.L.2
  • 3
    • 0028855831 scopus 로고
    • Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage
    • Aye MT, Palmer DS, Giulivi A, Hasemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;2:117-24.
    • (1995) Transfusion , vol.2 , pp. 117-124
    • Aye, M.T.1    Palmer, D.S.2    Giulivi, A.3    Hasemi, S.4
  • 4
    • 0027398561 scopus 로고
    • Increased tumor necrosis factor α (TNF-α), interleukin 1, and interleukin 6(IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF-α and IL-6 levels and febrile transfusion reactions
    • Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased tumor necrosis factor α (TNF-α), interleukin 1, and interleukin 6(IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF-α and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195.
    • (1993) Transfusion , vol.33 , pp. 195
    • Muylle, L.1    Joos, M.2    Wouters, E.3    De Bock, R.4    Peetermans, M.E.5
  • 6
    • 3042554701 scopus 로고    scopus 로고
    • Interleukin 1 beta and tumor necrosis factor levels in stored platelet concentrates and the association with gene polymorphisms
    • Addas-Carvalho M, Origa AF, Saad ST. Interleukin 1 beta and tumor necrosis factor levels in stored platelet concentrates and the association with gene polymorphisms. Transfusion 2004;44:996-1003.
    • (2004) Transfusion , vol.44 , pp. 996-1003
    • Addas-Carvalho, M.1    Origa, A.F.2    Saad, S.T.3
  • 7
    • 34247141876 scopus 로고    scopus 로고
    • Cytokine generation in stored platelet concentrates: Comparison of two methods of preparation
    • Chaudhary R, Aggarwal A, Khetan D, Dayal R. Cytokine generation in stored platelet concentrates: Comparison of two methods of preparation. Indian J Med Res 2006;124:427-30.
    • (2006) Indian J Med Res , vol.124 , pp. 427-430
    • Chaudhary, R.1    Aggarwal, A.2    Khetan, D.3    Dayal, R.4
  • 9
    • 0025777448 scopus 로고
    • Interleukin-1 and Interleukin-1 antagonism
    • Dinatello CA. Interleukin-1 and Interleukin-1 antagonism. Blood 1991;77:1627-52.
    • (1991) Blood , vol.77 , pp. 1627-1652
    • Dinatello, C.A.1
  • 10
    • 0029801619 scopus 로고    scopus 로고
    • Febrile reaction to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method
    • Muylle L, Wouters E, Peetermans ME. Febrile reaction to platelet transfusion: The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion 1996;36:886-90.
    • (1996) Transfusion , vol.36 , pp. 886-890
    • Muylle, L.1    Wouters, E.2    Peetermans, M.E.3
  • 11
    • 0025331306 scopus 로고
    • Tumor necrosis factor induces the production of urokinasetype plasminogen activator by human endothelial cells
    • van Hinsbergh VW, van den Berg EA, Fiers W, Doo? ewaard G. Tumor necrosis factor induces the production of urokinasetype plasminogen activator by human endothelial cells. Blood 1990;75:1991-8.
    • (1990) Blood , vol.75 , pp. 1991-1998
    • Van Hinsbergh, V.W.1    Van Den Berg, E.A.2    Fiers, W.3    Dooewaard, G.4
  • 12
    • 84859906134 scopus 로고    scopus 로고
    • Platelet concentrates from whole blood donations (buffy-coat) or apheresis: Which one to use?
    • Lozano ML, Rivera J, Vicente V. Platelet concentrates from whole blood donations (buffy-coat) or apheresis: Which one to use? Med Clin (Barc) 2012;138:528-33.
    • (2012) Med Clin (Barc) , vol.138 , pp. 528-533
    • Lozano, M.L.1    Rivera, J.2    Vicente, V.3
  • 13
    • 77953505982 scopus 로고    scopus 로고
    • Buffy-coat derived pooled platelet concentrates and apheresis platelet concentrates: Which product should be preferred?
    • Schrezenmeir H, Seifried E. Buffy-coat derived pooled platelet concentrates and apheresis platelet concentrates: Which product should be preferred? Vox Sang 2010;99:1-15.
    • (2010) Vox Sang , vol.99 , pp. 1-15
    • Schrezenmeir, H.1    Seifried, E.2
  • 14
    • 84969778053 scopus 로고    scopus 로고
    • Apheresis versus whole blood derived platelet concentrates: Pros and cons
    • van der Meer PF. Apheresis versus whole blood derived platelet concentrates: Pros and cons. ISBT Sci Ser 2012;7:112-6.
    • (2012) ISBT Sci ser , vol.7 , pp. 112-116
    • Van Der Meer, P.F.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.